Otonomy to Present at the Needham Virtual Healthcare Conference

Rhea-AI Summary

Otonomy, Inc. (Nasdaq: OTIC) announced participation in the 20th Annual Needham Virtual Healthcare Conference. David A. Weber, Ph.D., the company's president and CEO, will present an overview on April 13, 2021, at 4:30 p.m. ET. A live audio webcast can be accessed on Otonomy's website, with an archive available post-event.

The company focuses on developing innovative therapeutics for neurotology, utilizing drug delivery technology to create sustained drug exposure from a single local administration, specifically targeting hearing loss and tinnitus.

SAN DIEGO, April 06, 2021 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced its participation in the 20^th Annual Needham Virtual Healthcare Conference. David A. Weber, Ph.D., president and CEO of Otonomy, will present a company overview on Tuesday, April 13, 2021 at 4:30 p.m. ET (1:30 p.m. PT).

A live audio webcast of the presentation will be available through the Events page of the company's website (www.otonomy.com). An archived webcast of the presentation will also be available on the same web page shortly after the live event.

About Otonomy

Otonomy is a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology. The company pioneered the application of drug delivery technology to the ear in order to develop products that achieve sustained drug exposure from a single local administration. This approach is covered by a broad patent estate and is being utilized to develop a pipeline of products addressing important unmet medical needs with a focus on hearing loss and tinnitus. For additional information please visit www.otonomy.com.

Contacts:

Media Inquiries
Spectrum Science
Chloé-Anne Ramsey
Vice President
404.865.3601
cramsey@spectrumscience.com

Investor Inquiries
Westwicke ICR
Robert H. Uhl
Managing Director
858.356.5932
robert.uhl@westwicke.com

FAQ

What is Otonomy's participation in the Needham Virtual Healthcare Conference?

Otonomy is presenting at the 20th Annual Needham Virtual Healthcare Conference on April 13, 2021, at 4:30 p.m. ET.

Who will present at the Needham Conference for Otonomy?

David A. Weber, Ph.D., president and CEO of Otonomy, will present the company overview.

Where can I listen to Otonomy’s presentation?

The presentation will be available as a live audio webcast on Otonomy's website.

What innovative approach does Otonomy use for drug delivery?

Otonomy uses drug delivery technology that allows for sustained drug exposure from a single local administration.

What medical needs does Otonomy focus on?

Otonomy focuses on addressing important unmet medical needs related to hearing loss and tinnitus.